Search Tag: MS
Drug-for-treatment-of-multiple-sclerosis-approved
2013 20 Sep
A transformational new treatment for multiple sclerosis (MS) has been approved by the EU agency responsible for regulating new drugs. This is the result of over three decades of research in Cambridge. The European Medicines Agency (EMA) has approved the drug Alemtuzumab, to be known by the brand name Lemtrada and previously called Campath-1H...Read more
2nd-menactrims-congress-2016
2016 17 Mar
MENACTRIMS is an independent organization that facilitates communication and creates synergies among clinicians and scientists to promote and enhance research and improve clinical outcomes in multiple sclerosis (MS). The main objectives of the organization are as follows: To support and promote basic and clinical research in multiple sclerosis in...Read more
Know-more-treat-better
2019 22 May
Affidea applies ground-breaking AI technology on Brain MRI examinations for people with Multiple Sclerosis Affidea has entered into a partnership with icometrix, a data science company that develops Artificial Intelligence (AI) solutions for healthcare, to standardise and improve the care of patients with neurological disorders. The official...Read more